• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of amjphAmerican Journal of Public Health Web SiteAmerican Public Health Association Web SiteSubmissionsSubscriptionsAbout Us
Am J Public Health. 2007 October; 97(10): 1762–1774.
PMCID: PMC1994175

The Utilization of Testing and Counseling for HIV: A Review of the Social and Behavioral Evidence

Abstract

Against the background of debates about expanding HIV testing and counseling, we summarize the evidence on the social and behavioral dimension of testing and its implications for programs.

The discrepancy between acceptance of testing and returning for results and the difficulties of disclosure are examined in light of research on risk perceptions and the influence of gender and stigma. We also summarize the evidence on the provision of testing and counseling, the implementation of practices regarding confidentiality and consent, and the results of interventions.

We demonstrate that social factors have a considerable impact on testing, show that the services linked to testing are key determinants of utilization, and consider the implications of these findings for HIV testing programs.

Testing for HIV is the gateway to treatment, care, and prevention. To scale up treatment and prevention, rapid increases in both the volume of testing and the ability to counsel those who are tested are needed. The use of testing globally, however, is very low. Recent estimates based on surveys in 12 high-burden countries in sub-Saharan Africa indicate that a median of just 12% of men and 10% of women in the general population have been tested for HIV and received the results.1 Even in more developed countries, about 20% to 30% of seropositive individuals are unaware that they are HIV positive.2 This means that most people living with HIV get testing and counseling only when they already have advanced clinical disease. Concerns over the gap between needs and reality have led to urgent calls for dealing with this important “unfinished business” and expanding testing in developing countries.3

HIV testing is often used as an umbrella term to refer to both testing and counseling services. Diagnostic testing refers to HIV testing that occurs within a clinical care setting to aid in patient care management. Voluntary counseling and testing emphasizes the need for voluntary, informed consent prior to testing as well as pre- and posttest counseling. Routine testing in clinical settings, whereby patients are asked if they would like to be tested (“opt-in testing”) or are informed that they will be tested as part of routine procedures unless they refuse (“opt-out testing”), is increasingly advocated. This is different from “routinely” conducting tests in medical settings without informing patients or seeking their consent. The terminology reflects ongoing debates about consent, as well as the tension between safeguarding individual rights and protecting public health: should testing be universal, routinely practiced, routinely offered, or only performed at an individual’s request and where indicated for individual cases? Is voluntary counseling and testing the only way to ensure consent?46

In an effort to avoid the potential confusion of earlier terminology, the World Health Organization (WHO) has recently proposed a formulation that distinguishes between 2 types of HIV testing, both voluntary: client-initiated testing, corresponding to what is usually referred to as voluntary counseling and testing, and provider-initiated testing. The latter is conducted at health facilities as part of clinical care to diagnose patients who present with signs and symptoms suggestive of HIV or to aid in providing care to nonsymptomatic patients in areas of high prevalence or at clinics used by populations that may be at special risk of HIV.7

The history of HIV testing shows that the issue has always stirred much controversy. In the mid-1980s, when tests became available, public health measures that were commonly accepted for other diseases (such as compulsory testing, contact tracing, and quarantine) were called into question. Fears of the social and political consequences of mandatory reporting of HIV-positive status, and concerns that such measures could lead to discrimination and “drive the epidemic underground,” prevailed over traditional public health approaches, and only confidential and anonymous testing was considered acceptable.8 With the availability of treatment, however, such exceptionalism came to be less defensible, and scaled-up testing is increasingly advocated both as a gateway to treatment and prevention and as a way to “normalize” and destigmatize HIV.911

Support has been growing for incorporating HIV testing and counseling into routine health care, including prenatal care, care for sexually transmitted infections, hospitalization, or even general primary care. Research showing that voluntary counseling and testing is associated with the adoption of preventive behavior12,13 and that routine screening for HIV is cost-effective14 has bolstered the position of those in favor of expanding testing programs. Some observers, however, continue to express caution over the potential stigma, discrimination, and violence that may be associated with disclosure of HIV-positive status.15,16 Supporters argue that concerns over the protection of individual rights should not prevail over the public health benefits of expanded testing.10,17

In 2004, WHO and the Joint United Nations Program on AIDS (UNAIDS) had recommended the routine offer of testing with the choice to opt out5; in 2007, they issued a Guidance for Provider-Initiated Testing and Counseling in Health Facilities.7 In 2006, the Centers for Disease Control and Prevention (CDC) called for routinely testing people aged 13 to 64 years and for simplifying the process of obtaining consent.18 Recommendations to expand testing raise numerous questions about the application of the policy and its consequences in different settings. These questions relate to the feasibility of providing the needed referral, treatment, and prevention services related to HIV testing; the protection of individuals identified through testing; whether it is truly possible to “opt out” of testing; ensuring consent and confidentiality; and the extent to which routine testing encourages prevention, reduces stigma, and promotes behavior change.

The evidence needed to inform debates about the best way to implement testing and counseling programs is patchy. Although statistics are increasingly available, and there have been comparative studies of the effectiveness of voluntary counseling and testing,12 less is known about the factors that influence utilization in different settings, with some studies casting doubt on the notion that the positive effects observed in small studies are necessarily replicated as testing expands.19 Nor do we understand the reasons for differential use, even though discussions often refer to gender, stigma, or poverty as obstacles to the utilization of testing. The issue of HIV testing is often addressed as if all HIV tests were conducted for the same purposes and under the same circumstances.

There are, however, important differences between voluntary counseling and testing, testing conducted for diagnostic purposes among ill patients, routinely offered testing at health facilities, testing for purposes of surveillance among healthy populations, and mandatory testing that is carried out when required by law—each of which may require different information and different standards to ascertain consent and ensure confidentiality. The epidemiological context in which testing is conducted also makes a difference—high- or low-prevalence settings have different implications for the identification of HIV-positive individuals or so-called “risk groups.”

In general, the operational evidence to inform policies is insufficient, and little is known about how guidelines about testing are in fact implemented, especially in high-prevalence countries, which factors facilitate utilization, and to what extent testing is accelerated when treatment becomes available. And yet it is information about context, attitudes, and behaviors that is most urgently needed to improve programs. After all, whether testing does open the gate to treatment and promotes prevention depends in large part on the extent to which fears of testing are overcome, adverse consequences of disclosure are avoided, and providers can connect clients to appropriate treatment and prevention services. This, in turn, requires an understanding of the contextual factors that facilitate or hinder testing, both within health facilities and elsewhere.

We focus on 1 set of factors related to the utilization of testing and counseling, namely those related to the users and providers of services, their interactions, and the context of those interactions. Our analysis, based on a review of the literature on the sociobehavioral dimension of testing and counseling, is designed to complement analyses that focus on the epidemiological, managerial, and policy dimensions. Given that the evidence is disparate and that the goal of the analysis was not to test a specific hypothesis, it was neither feasible nor desirable to carry out a proper meta-analysis; we thought a systematic summary was more appropriate for highlighting the main themes that emerge from existing studies.

METHODS

We included sources on all the different approaches to testing and refer to the process by the term testing and counseling, which implies that counseling is provided along with testing, unless otherwise indicated. The literature on HIV testing and counseling is vast. For example, a MEDLINE search on HIV infections with a focus on diagnosis retrieved 6547 references for the period January 1996 to April 2005; a similar search using EBSCO retrieved 11 338 titles. Such large numbers make it difficult to thoroughly review all the sources. Interestingly, as illustrated by the Prevention Research Synthesis Project of the CDC, searching selected sources by hand can often be more productive than simply relying on computerized searches.20 Hence, a combination of focused computerized retrieval and hand searching was adopted here.

The following databases were searched for articles on HIV testing that have appeared since January 1996: PubMed, Psych Info, SocioFile, and Social Science Index. We used the intersection of 2 sets of keywords: HIV infections and HIV antibodies, and test(ing) and diagnosis. To exclude purely biomedical and microbiological studies, we narrowed down our search through use of the keywords behavior, risk factor, surveillance, interview, focus group, and social science, thereby retaining articles with social and behavioral information on providers or clients. Titles were scanned, and 550 abstracts and articles dealing with behaviors related to HIV testing were retrieved.

After the database searches were completed, we conducted focused searches, based on prior knowledge of particular research projects and the suggestions of experts in the area. We also reviewed bibliographies of major articles; collected documents by UNAIDS, WHO, and the CDC; and searched Web sites of key organizations whose work deals with HIV testing. In this way, we further retrieved 150 abstracts and 35 articles, for a total of about 700 abstracts and 200 articles. We also made an effort to include the main results from conference abstracts and articles that appeared between acceptance of the manuscript and publication date, thus adding about 150 more sources to the database.

THE EVIDENCE ABOUT TESTING

A considerable proportion of the information on the levels and demographic determinants of testing comes from studies of specific groups at risk. In low-HIV-prevalence countries of the Northern Hemisphere, attention has been directed primarily at men who have sex with men, as well as migrants and intravenous drug users. In Africa, most studies come from programs for pregnant women and high-risk groups such as mine workers, truck drivers, and sex workers.

The statistical evidence on HIV testing is growing, thanks both to national surveys and surveys among particular populations. It shows that coverage is low everywhere, including in many high-prevalence countries.4,21,22 Despite the wealth of statistics, however, comparative analyses have been limited. Few analyses have investigated differentials in utilization to derive general patterns, such as the association of education, income, or gender with behavior regarding testing. Most studies tend to focus on measuring the statistical associations among variables that are detached from their social context. These explanatory frameworks, often inspired from psychology, have tended to be individualistic and to assume a rational and unidirectional connection between ideas and behaviors—an assumption that is not always tenable. A few studies have used microlevel ethnographic or qualitative methods, but they tend to be limited to small samples whose representativeness is unknown. As has been observed for research on sexual behavior and HIV, few studies have overcome the barriers between disciplinary boundaries and integrated qualitative and quantitative approaches.23,24

The diversity of policies regarding testing and counseling underscores the multiplicity of approaches to testing and what it means in different contexts. For example, in Botswana since 2004, prenatal care programs began to implement opt-out testing and counseling; this resulted in higher rates of testing, raising questions about the ethical aspects of scale-up.25 In Uganda, where the Ministry of Health has revised its policy guidelines, several models for providing testing and counseling coexist: the routine offer of testing at health facilities, home-based voluntary counseling and testing whereby individuals are offered testing and given results in their home, and traditional freestanding voluntary counseling and testing centers. In Burkina Faso, the rate of testing has increased, despite very limited treatment.26,27 India’s private hospitals are said to conduct mandatory testing on prospective surgical patients, and some studies have in fact documented that many Indian patients are tested without consent.28,29 In Holland, opt-out testing in prenatal care clinics has been implemented for several years.

Debates about policies reflect the shifting context of testing as a result of the availability of treatment. They also serve to illustrate the difficulty of reconciling the protection of the privacy of HIV-positive individuals with concerns for the safety of others who may be endangered if information is withheld. The possibility of allowing health workers to disclose patients’ status to their partners has been discussed in African countries, where it is referred to as “beneficial disclosure.”30,31 In Singapore, the Health Ministry makes it mandatory to inform the spouses of HIV patients.32 Such examples underscore the need for information about the implementation of guidelines regarding consent and confidentiality in different settings.

In the remainder of this article, we summarize the evidence on the social and behavioral dimension of testing and the statistical evidence implications for programs. In the first part of the analysis, we consider statistics on testing and individuals’ reluctance to be tested, get results, and disclose their status. We examine patterns of testing and disclosure in light of research on social and behavioral determinants, including the role of risk perception and the influence of gender and stigma. In the last part of the article, we shift attention to health facilities and review the evidence on how services linked to testing are provided, the role of providers, the provision of counseling, the implementation of practices regarding confidentiality and consent, and the results of interventions.

ACCEPTANCE OF TESTING AND RETURNING FOR RESULTS

An examination of statistics on testing and counseling reveals a large discrepancy between levels of acceptance of testing and levels of returning for results (Table 1 [triangle]). This discrepancy reflects the conditions that prevailed with the first generation of tests, still used in some low-prevalence countries, which require delays of about 2 weeks between testing and results, in contrast to recent tests, which can give results in about 20 minutes. A comparative analysis indicates that with delayed results, the percentage of the population agreeing to be tested frequently reaches 80% or 90%, but the percentage who return to get their results is much lower, around 60% of those who get tested.60 An international mailing survey on attitudes toward testing in 13 sites in Asia and Africa found near-universal acceptance of testing but lower rates of returning for results.61

TABLE 1
Studies on Rates of Patients Who Return for HIV Test Results and Rates of Disclosure of Test Results to Partners

In studies in the United States, primarily among clients at clinics for sexually transmitted infections, between 10% and 66% of individuals did not return for results.40,52,57,62 In African settings, it has often been shown—for example, in a Dar es Salaam study,45 in a study of Rwanda antenatal clinics,46 and in another of Kenya antenatal clinics44—that approximately one third of clients do not return for results. In some African studies, the proportion was even higher. In a study of male factory workers in Zimbabwe, almost one half did not return for results.48 In Abidjan, Ivory Coast, where 78% of women attending prenatal care expressed acceptance of testing, only 58% returned for results.34 In Zambia, acceptance of testing was about 50%, but rates of completing the process and returning results was as low as 12%.37 Among South African women who did not accept antenatal screening, none wanted to know their status, and 44% were in fact HIV positive.63 Often, those less at risk tend to be more interested in knowing their status.51,64 Even in Burkina Faso, where the increase in voluntary testing and counseling has been phenomenal, utilization is higher among low-risk groups, and many pregnant women do not return for results.34,53 The fact that this discrepancy between testing and returning for results holds across settings underscores the importance of the problem and the need for a better understanding of the factors that account for it.

Refusal to be tested or to obtain test results has been attributed in part to obstacles of cost and transportation and to the burden of having to return to health facilities. Rapid tests and home testing have been advocated to address these difficulties. We summarize recent evidence about these new approaches in the last part of this article.

PERCEPTION OF RISKS AND CONSEQUENCES OF HIV

Although it is clear that practical constraints, delays in test results, and lack of knowledge hinder the utilization of HIV testing, the major barrier is individuals’ reluctance to acknowledge that they are at risk even when in fact they are; this has been documented in studies in the United States and Canada,6567 rural Tanzania,68 Ethiopia,55 northern Thailand,69 among pregnant women in the United Kingdom,7072 and among poor Brazilian women whose partners are HIV positive.73,74

The fact that individuals’ perceptions of their risk of HIV do not match objective assessments, and that information does not necessarily translate into risk avoidance, is consistent with the literature on health behavior in general. Studies repeatedly show that correct and erroneous notions of transmission and treatment coexist; they also document behaviors that are at odds with professional perspectives, such as doubting the existence of HIV, denying dangers, inexplicable optimism, the exaggerated concerns of those not at risk, failure to adopt protective behaviors, and stigmatization of victims.23,24,7579 Whether or not there is something about HIV that has made it a more fertile terrain for apparently “irrational” beliefs and behaviors—the mystery surrounding its origins, the uncertainty of prognosis, or its association with human relationships—the point is that information about HIV is often confusing, has emotional connotations, and cannot simply be reduced to its medical content.

A recurrent finding is that the main reason people do not take HIV tests or return for results is fear. This is not surprising, since HIV is life threatening. But fear is also about the social consequences of the illness—rejection by loved ones, loss of job or housing, discrimination, and violence.80 In addition, where it is a terminal illness, HIV represents a breakdown in the ties of reciprocity that link individuals, because it is not worth “investing” in a relationship with someone who will not be around for long; this may lead to ostracism and isolation.81

A frequently observed pattern is the discrepancy between intent to be tested and actual behavior. Because of worries about consequences, individuals often do not execute their plan to take HIV tests.72 In 6 African countries, a reported two thirds or more of respondents stated they would like to get tested, but the proportion of those who reported being tested was much lower, around 15% in some settings.19 Rates of failure to be tested among those who intended to be can be as high as 70%.82 Individuals may plan to inform partners and return for joint counseling but then change their minds. In a study of mothers in Zaire, such intentions were as high as 70%, but only 2% followed up 12 months later.39 Although several of the studies have limitations in that they ascertained intent through simple direct questions, the disconnect between intentions and behaviors makes sense if considered in light of the difficulty of dealing with the multiple social and medical consequences of the illness.

The significance of HIV tests goes well beyond the information about serostatus that they provide; their results have a powerful impact on patients’ lives, often leading to a complete redefinition of a person’s social relationships. It is in this light that one needs to consider appeals to the “right to know” one’s HIV status as implemented in some programs.17,83,84 Although this approach may work in some settings, the effectiveness of casting HIV tests in a rights discourse needs to be assessed against evidence about how it resonates with local views. Where individuals, far from feeling entitled to know their status, are fearful of results and ambivalent about tests, complementary approaches should be explored.

MEANINGS OF TESTING AND DIFFICULTIES OF DISCLOSURE

Levels of disclosure and partner involvement after tests are variable and generally low. In Tanzania, one study found that only 22% of women had told their partners of their status after 2 months, and 40% had disclosed their status after 4 years33; another study found that 64% of HIV-positive and 80% of HIV-negative women had disclosed their status to their partners.50 In Burkina Faso, only 18% of women made disclosure to their partners53; in Zaire, only 2% of women brought their partners for testing39; in a US study of gay men, 41% had not disclosed their status to their partners.42

Qualitative studies that interview people who have been tested indicate that test results have meanings that are tied to relationships, faithfulness, and trust, and that they may be interpreted in relation to the love or loyalty of a partner. As individuals take HIV tests when they are ending a relationship or starting a new one, disclosure of test results serves to mark such life transitions.8589 Disclosure, therefore, is not simply about conveying medical information. It is often not a definitive move but rather an iterative process fraught with hesitations and retractions.9093 In some settings, there are also fears that speaking about the disease may accelerate its course,94,95 and silence seems a safer option. When disclosure does take place, it may be not to the partner but to another member of the family or to a friend.47

The adverse consequences that may follow disclosure have frequently been highlighted, but the evidence is limited and somewhat contradictory. In the United States, a recent systematic review of partner notification services found few negative consequences overall, whereas individual studies have reported negative reactions, including violence, in around 4% of cases.38,54 A study in Tanzania found that about 50% of women experienced positive responses, and other studies (in Kenya and Zambia) found that most HIV-positive women reported positive outcomes, including some who feared they would not receive support.41,50,101 A review of 17 studies in developing countries found that negative consequences of disclosure, including violence, were reported in 3% to 15% of cases.96 Violence and abuse, however, are only the most dramatic of the adverse consequences of disclosure; other reactions ranging from exclusion to expulsion may be more common (see “Influence of Stigma on Testing”).

It is difficult to assess to what extent negative reactions relate to testing per se, since often those who suffer them live in difficult conditions where they may be habitually mistreated. Although the evidence does not allow comparisons of levels of abuse before and after notification, the distinction could be useful, because negative reactions that directly result from HIV testing may respond to specific interventions linked to testing, while those that reflect societal discrimination are less amenable to change without broader interventions.

THE ROLE OF GENDER IN SHAPING MOTIVATIONS AND REACTIONS

Research indicates that everywhere, gender powerfully shapes attitudes toward testing (Table 2 [triangle]). Men tend to underestimate their risk for HIV infection more than do women, despite reporting more high-risk behaviors, and women have more fears about testing than do men.55,56 Some studies have found that men are more responsive to mass communications, leaflets, and peer pressure, and women to personal and emotional considerations, rather than objective risk assessments.99,106108 Although these studies are of uneven quality, this evidence is consistent with others showing that HIV risk perceptions are strongly influenced by gender.56,109 A national survey of France showed that women seek to reduce risks by focusing on the personal dimension of their situation, such as trying to find out more about their partners and building trust with them; men, by comparison, are more inclined to adopt specific behaviors such as condom use.110 Intervention studies show that the information–motivation–behavior models that are usually successful in explaining men’s responses to behavior change interventions appear to fall short when trying to predict women’s responses.103

TABLE 2
Studies on Role of Gender in HIV Testing

The negative consequences of testing and fears of disclosure are more frequently documented for women, and this fits with the evidence that outside of prenatal care programs, women are tested less frequently than men.111 Much of what we know, however, comes from studies of HIV testing among pregnant women. Because pregnancy is a time when women need special support and are fearful of abandonment, it is among this group that fears of abuse are most manifest and the gap between testing and getting results greatest.33,38,49,68,81,84,94,112116

Although not all studies confirm gender differences in general attitudes toward testing,37,117 differences in specific motivations are consistently documented. Women’s decisions about testing appear to be complicated by their plans to have children, their husband’s opinion, and their breastfeeding plans.55,97,100 A recent comparative study in 4 Asian countries (India, Indonesia, the Philippines, and Thailand) found that men were more likely to be tested if they had HIV-related symptoms, whereas women were more likely if their partner tested positive,105 a pattern that confirms gender differences in exposure to HIV and women’s more vulnerable position.

INFLUENCE OF STIGMA ON TESTING

A recurrent theme in the literature on HIV concerns the role of stigma in impeding the utilization of testing. As the mark of a socially undesirable characteristic that leads to a “spoiled identity,” stigma has long received attention from the social sciences, starting with the analyses of Goffman118 and more recently with operational research on stigma and various diseases.119,120 Heightened awareness of the potential for discrimination against people living with HIV/AIDS has given stigma a central role in policy and program discussions. Stigma against HIV is reported to be pervasive and to be the main reason for the reluctance to be tested, to disclose HIV status, or to take antiretroviral agents. This has been documented in numerous countries, including South Africa, Indonesia, Tanzania, Botswana, Ethiopia, Ghana, India, Uganda, Thailand, and Zimbabwe.121135 Even in health care settings, health workers may stigmatize patients by treating them differently, using excessive precautions, or withholding appropriate care.105,136139

Although stigma and discrimination against people living with HIV/AIDS have been amply documented, and although fear of stigma is consistently reported to be a deterrent of testing, few studies provide quantifiable measures of the effect of stigma on HIV testing.140 Part of the reason is related to the dominance of psychological models in HIV behavioral research, which results in a preponderance of cognitive measures of stigma (e.g., what percentage of a given population hold particular negative beliefs about people living with HIV/AIDS) rather than measures of actual stigmatizing behaviors and their consequences. This tendency is reinforced by the ease with which information on beliefs can be collected in surveys, compared with the difficulty of observing behaviors or analyzing the broader societal forces that influence stigma.141,142

Some observers have also noted a degree of “conceptual inflation” in analyses of stigma, whereby many consequences are attributed to it without a thorough examination of alternative explanations and related factors.141 The various disadvantaged groups that tend to be stigmatized suffer the simultaneous consequences of a multiplicity of undesirable characteristics—for example, poverty, drug use, and HIV-positive status. It is thus difficult to disentangle the effect of these different “layers” of stigma and to assess the specific impact of stigma related to HIV status, as compared with other characteristics.143

These points are not simply academic but have implications for programs designed to increase treatment and care utilization. If stigma and discrimination specific to HIV impede testing, then evidence is needed on those factors that are amenable to change and that would encourage people to use needed services—what economists would refer to as “demand” factors; conversely, if “normalization” of testing reduces stigma, then the emphasis would be on increasing and improving the “supply” of testing. Recent summaries of the multiple measures of stigma and of interventions to reduce it provide useful conceptual and methodological tools144147 and can advance our understanding of the links between stigma, the utilization of HIV testing, and the “normalization” of HIV.

WHO COUNSELS THE COUNSELORS?

Counseling has, until recently, been an integral part of HIV testing. It typically involves a face-to-face session in which a trained counselor provides information about HIV (what the test means and how to prevent transmission), helps clients identify ways to avoid the behaviors that put them at risk, and where appropriate, refers them to services. Under the voluntary counseling and testing model, some counseling is provided before the test, designed to give information and obtain consent; in posttest counseling, the balance of information, encouragement of preventive behavior, and referral depends on whether test results are positive or negative. Because of the nature of HIV and the implications of a positive diagnosis, in communicating about the test great care must be taken to avoid misunderstandings, convey the seriousness of the diagnosis without leading the patient to despair, and encourage appropriate behaviors.

Although numerous guidelines have been formulated to improve counseling, the limited evidence about how testing and counseling are implemented shows great variations in quality. There are considerable differences between well-resourced facilities that provide voluntary counseling and testing and those where HIV testing and counseling are added to the already stretched health services. Where health systems are weak and resources limited, providers may have had insufficient training, and their workloads may be so heavy that they do not find the time or space for counseling. Even when recommended, testing and counseling may not be systematically provided,60 and decisions about whom to test are made on the basis of providers’ perceptions of clients’ ability to take potentially bad news.148 Some studies find that time for counseling is insufficient,149 the information often not adequate, and the quality of counseling lower for clients from the less-privileged segments of society.150

Increasingly, staffing constraints, overloaded facilities, and doubts about usefulness appear to be eroding support for the provision of pretest counseling at health facilities and building support for concentrating on posttest counseling. The latest CDC guidelines on HIV testing in health care settings make counseling advisable but not mandatory, and they streamline pretest informed consent into a standard requirement for consent to all medical tests. A recent Journal editorial called for skipping pretest counseling altogether on the grounds that it is not useful.10 It is unclear whether the omission of pretest counseling facilitates testing by eliminating a possibly cumbersome practice or whether it hinders testing because clients do not receive needed advice or information. Clearly, more evidence is needed to inform guidelines and tailor requirements to the particular type of testing, whether at voluntary counseling and testing facilities or in the context of clinical care or services to prevent mother-to-child transmission.

The issues surrounding counseling represent a major challenge for the utilization of testing. Much is expected of providers “on the front lines,” but little is known about how they cope. In addition to practical difficulties, they must deal with their own emotional issues regarding HIV.151 They may be reluctant to be tested and themselves suffer stigma138; they may fear contamination and feel helpless, pessimistic, and doubtful of their ability to provide care.151154 This makes it difficult to communicate with clients and encourage them to adopt appropriate behaviors. Conversely, good rapport between providers and clients is an important determinant of patients’ acceptance of clinic-based interventions, including testing.54,67,155

Attention should therefore be directed at providers to define the needed services and ascertain the training, time, and resources necessary to deliver them. The question of how to support providers so that they gain clients’ trust is an important one, and answers are likely to refer to both the characteristics of the providers themselves and the functioning of the health system in which they operate.

CONSENT AND CONFIDENTIALITY IN PRACTICE

Testing for HIV has long elicited concerns regarding the costs and benefits to patients, the implementation of informed consent, and the protection of privacy. Proposed moves to expand testing have heightened awareness of the ethical dimension of testing and counseling. Because debates about ethics often take place without the benefit of evidence, there have been calls for “evidence-based bioethics” and for information from the field as a “reality check” for “principled” discussions.”156158 Accordingly, we focus here on practices, particularly those related to consent and confidentiality.

Information about how ethical principles are applied to HIV testing is mostly indirect, coming principally from studies of informed consent to research. Although the principles are not the same for research and testing, the evidence suggests that informed consent is a social process shaped by power relationships and by culture159 and that participants often do not understand the information given to them.160163 Studies of testing in Europe indicate that 10% to 20% of respondents are tested without their knowledge.164166 Participants may agree to be tested because they are used to agreeing to health professionals’ requests,167 think that they will receive improved care,168 do not think they can decline,169 or have a diffuse sense that refusing would have adverse consequences.170172

Practices to protect confidentiality are unevenly applied. Confidentiality may not be viewed positively, especially if it is seen to protect irresponsible individuals.173 The difference between confidential and anonymous testing may not be understood, and providers have to negotiate a potential tension between the program advantages of confidential testing and their clients’ preferences.174 A number of studies show that confidentiality is often compromised by established practices in health services and by differential regard for clients’ rights,125,150 with poor women at a distinct disadvantage.153 In a comparative study in India, Thailand, the Philippines, and Indonesia, breaches of confidentiality by health care workers were reported by 34% of respondents.105 There is evidence that perceptions of how confidentiality is handled influence clients’ willingness to be tested.37

The acute need to balance efforts to scale up testing with the protection of individual rights has repeatedly been underlined, and empirical evidence on practices and attitudes in multiple settings is needed to identify innovative ways to adapt ethical principles to local situations.

IMPLICATIONS OF INTERVENTIONS FOR PROGRAMS

Research on programs provides useful insights into the interventions and the features of services that are associated with the uptake of testing. Several studies include detailed information about what seems to work—for example, that information per se is not sufficient, that the effectiveness of written materials compared with verbal communication depends on the setting, that targeted media campaigns are effective for some risk groups, and that efforts to adapt decisionmaking to clients’ preferences can be effective.99,107,113,175177 Although not unexpected, these results show that it is possible to modify health services to make them more responsive to clients’ needs and preferences and hence promote the utilization of testing. Improving the quality of testing and counseling services can lead to significant increases in rates of testing, as documented in South Africa178 and Brazil.179

Intervention studies of the conditions under which testing is administered document the effect of provider–client interactions on the utilization of testing. Clients’ responses are influenced by providers’ background characteristics (such as gender or ethnic group), attitudes, and perseverance and the extent to which they are trusted by their clients.180,181 Several studies underscore the importance of the personal element and the context in which testing takes place. When the risks of HIV are personalized and messages are framed in terms of personal gains and losses, the intervention appears to be more effective. This is consistent with research showing that individuals need to translate statistics and abstract notions of risk into personal terms, and that stigma and prejudice are decreased when individuals have personal acquaintances who are HIV positive.182184

New approaches to the delivery of testing services have had positive effects on utilization. Using rapid tests and providing tests in locations and in conditions that are convenient to clients—such as at workplaces, health facilities, and mobile clinics and at night—have been shown to increase utilization; home-based voluntary counseling and testing facilitates reaching family members, and the routine offer of testing in clinical settings appears to overcome many of the barriers that hindered earlier efforts.178,179,185189 In Demographic and Health Surveys, the vast majority of respondents consent to giving blood samples for HIV tests and receiving results at home, and qualitative studies conducted in parallel with these surveys have not uncovered major problems of understanding or coercion.190 In Uganda, home testing increased acceptance of testing from 10% to 46% and eliminated differences in acceptance between women and men. Interviews and focus group discussions indicate that home testing avoids the inconvenience, fears, and costs of facility-based tests.58

A somewhat unexpected finding of studies that have examined different models of provision is that provider-initiated testing and counseling in the context of medical care elicits little opposition. Pregnant women are inclined to be tested if they think it can benefit their baby,71,191193 and utilization increases rapidly when testing is routinely discussed and offered and is well integrated into antenatal care.192,193 Under such circumstances, routine testing seems to be acceptable and to cause less anxiety for women than “opt-in testing.”70,193 A possible reason is that unlike opt-in testing, routine testing, ostensibly done for the benefit of the baby, does not make assumptions about women’s behaviors and hence does not threaten women’s sense of moral worth.89

Similar positive attitudes toward routinizing tests are observed outside of prenatal care. When hospitalized patients in the United States were asked how they would feel about an unsolicited HIV test, most responded positively.194 A comparison of 3 models of provider-initiated HIV testing and counseling in a tuberculosis clinic in Kinshasa, Congo, found that more than two thirds of clients preferred “opt-out” testing, where the test would be performed unless they declined, notwithstanding common perceptions that it would be difficult to decline the test.195

In general, findings about provider-initiated testing in care settings are also encouraging. The acceptance of testing increases considerably after it is routinely offered by providers, as documented in postpartum wards in Botswana,196 pediatric wards in Zambia,197 tuberculosis clinics in Congo,195 and Ugandan pediatric wards,198 maternity wards,199 and STI clinics.200 In Uganda, increased HIV testing appeared to be associated with clinical benefits for patients; people diagnosed as HIV positive after provider-initiated testing and counseling was introduced at Mbarara Hospital were at an earlier clinical stage and had higher CD4 counts than those identified beforehand and were therefore more likely to be referred to treatment at an appropriate time.201

There are concerns that provider-initiated HIV testing and counseling could deter clients from accessing health services. Although limited, the available evidence does not support those fears. The introduction of provider-initiated HIV testing and counseling in antenatal care clinics in Botswana appears to have caused neither reduction in the use of prenatal care nor decline in the proportion of people receiving test results,202 and in Zimbabwe it has had no negative effects on posttest counseling rates or the delivery of antiretroviral prophylaxis.203

These results are encouraging but raise questions about their applicability in different settings. To what extent does acceptance of routine testing in the context of prenatal care truly benefit the mother and baby by ensuring that results are obtained and referrals for prevention and care are in place? Will the positive outcomes of testing, as conducted through well-funded efforts and by combining testing and health care, be replicated in settings with fewer resources? Similarly, situations where the rate of voluntary counseling and testing is high despite limited treatment—as in Burkina Faso and Malawi,26,27,155 and in the context of sero-prevalence surveys conducted by Demographic and Health Surveys, where treatment is not provided—raise questions about what level of treatment needs to be ensured before testing is expanded. What does the routinization of testing mean for clients and potential clients—does it encourage testing, as suggested by the evidence on provider-initiated testing and counseling, or discourage it, as some observers fear?25,169 Answers to these questions will require both more evidence from various settings and policy discussions about the ethics of scale-up under different circumstances.

CONCLUSIONS

This review highlights the multiple influences on the utilization of HIV testing. It is clear that practical obstacles of cost and transportation hinder clients’ use of testing, and that constraints of training, time, and resources limit providers’ ability to offer quality services. Social factors related to clients’ attitudes and perceptions also make a difference, in particular the discrepancy between real and perceived risks, the emotional connotations of HIV tests, gender differences in motivations for and consequences of testing, and fears related to stigma and negative reactions to disclosure; similarly, providers’ concerns, their interactions with clients, and the level of trust in the provider–client relationship also appear to influence the utilization of testing.

The evidence, however, is patchy, particularly regarding the effect of stigma, the consequences of disclosure, and the extent to which practices related to confidentiality and consent have an effect on the utilization of testing.

The provision of testing has been changing. Rapid tests have eliminated some of the obstacles to returning for results observed in earlier studies; home testing is making it easier for individuals to accept testing; the routine offer of testing in prenatal care settings appears to elicit positive responses. The routinization of testing in medical settings, through provider-initiated testing and counseling, has tended to lead to positive outcomes in terms of acceptance of testing and linkage to services, but questions remain about the place of counseling in the testing-and-counseling package and the gradual erosion of pretest counseling—how much counseling is necessary, who will provide it, and under which conditions. More information is needed about how changes in the provision of information and counseling and in the process of securing consent will affect the utilization of testing, the quality of the care provided, and the appropriate referral of clients to care and treatment services.

Regardless of the specific model that is adopted, 2 things are clear. First, providers are under increased pressure to provide quality services. They will need support to provide them with the ability, resources, and motivation to inform, support, refer, and treat those who are diagnosed with HIV. Secondly, a one-size-fits-all approach is unlikely to work, and attentiveness to the personal dimension, local context, and social context of testing and counseling is necessary to identify best practices and malfunctions and to take this information into account in the planning of services.

Notes

Peer Reviewed

Contributors C. M. Obermeyer conceptualized and directed the review and wrote the article. M. Osborn conducted the searches, managed the database, provided summaries, and contributed to writing parts of the article.

References

1. Towards Universal Access: Scaling up Priority HIV/ AIDS Interventions in the Health Sector. Progress Report. Geneva, Switzerland: World Health Organization; 2007.
2. Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention. Basic statistics. 2004. Available at: http://www.cdc.gov/hiv/topics/surveillance/basic.htm. Accessed July 31, 2007.
3. De Cock KM, Bunnell R, Mermin J. Unfinished business—expanding HIV testing in developing countries. N Engl J Med. 2006;354:440–442. [PubMed]
4. USAID, UNAIDS, WHO, UNICEF. Coverage of selected services for HIV/AIDS prevention, care and support in low and middle income countries in 2003. Washington, DC: Policy Project; 2004.
5. UNAIDS/WHO Policy Statement on HIV Testing. Geneva, Switzerland: Joint United Nations Program on AIDS and World Health Organization; 2004.
6. Csete J, Schleifer R, Cohen J. “Opt-out” testing for HIV in Africa: a caution. Lancet. 2004;363:493–494. [PubMed]
7. NHO and UNAIDS 2007. Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities. Geneva, WHO; 2007.
8. Bayer R. Public health policy and the AIDS epidemic: an end to HIV exceptionalism? N Engl J Med. 1991;324(21):1500–1504. [PubMed]
9. De Cock KM, Johnson AM. From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. BMJ. 1998;316:290–293. [PMC free article] [PubMed]
10. Koo DJ, Begier EM, Henn MH, Sepkowitz KA, Kellerman SE. HIV counseling and testing: less targeting, more testing. Am J Public Health. 2006;96: 962–964. [PMC free article] [PubMed]
11. Manavi K, Welsby PD. HIV testing. BMJ. 2005; 330:492–493. [PMC free article] [PubMed]
12. The Voluntary HIV-1 Counselling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet. 2000;356:103–112. [PubMed]
13. Bunnell R, Ekwaru J, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20(1):85–92. [PubMed]
14. Bozzette SA. Routine screening for HIV infection—timely and cost-effective. N Engl J Med. 2005;352(6): 620–621. [PubMed]
15. Maher JE, Peterson J, Hastings K, et al. Partner violence, partner notification, and women’s decisions to have an HIV test. J Acquir Immune Defic Syndr. 2000; 25:276–282. [PubMed]
16. UNAIDS Reference Group on HIV AIDS and Human Rights. Ensuring a rights-based approach to HIV testing. Health Hum Rights. 2006;8:40–45. [PubMed]
17. De Cock KM. HIV testing in the era of treatment scale up. Health Hum Rights Int J. 2006;8:31–35. [PubMed]
18. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR-14):1–17. [PubMed]
19. Glick P. Scaling up HIV voluntary counseling and testing in Africa. Eval Rev. 2005;29:331–357. [PubMed]
20. Des Jarlais DC, Semaan S. HIV prevention research: cumulative knowledge or accumulating studies? An introduction to the HIV/AIDS prevention research synthesis project supplement. J Acquir Immune Defic Syndr. 2006;30(suppl 1):S1–S7. [PubMed]
21. Demographic and Health Surveys. HIV/AIDS survey indicators database. 2006. Available at: http://www.measuredhs.com/hivdata. Accessed July 31, 2007.
22. Joint United Nations Program on AIDS (UNAIDS), Baggaley R. The Impact of Voluntary Counselling and Testing: A Global Review of the Benefits and Challenges. Geneva, Switzerland: UNAIDS; 2001.
23. Moatti JP, Souteyrand Y. Editorial: HIV/AIDS social and behavioural research: past advances and thoughts about the future. Soc Sci Med. 2000;50: 1519–1532. [PubMed]
24. Obermeyer CM. Reframing research on sexual behavior and HIV. Stud Fam Plann. 2005;36:1–12. [PubMed]
25. Rennie S, Behets F. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ. 2006;84:52–57. [PMC free article] [PubMed]
26. Voluntary Testing and Counseling in Burkina Faso 2004: Report on Activities [in French]. Ouagadougou, Burkina Faso: Programme d’Appui au Monde Associatif et Communautaire; 2005.
27. Some J-F. Statistics on the Activities of Voluntary Counseling and Testing in Burkina Faso in 2002 [in French]. Ouagadougou, Burkina Faso: Programme d’Appui au Monde Associatif et Communautaire; 2003.
28. Elamon J. A situational analysis of HIV/AIDS-related discrimination in Kerala, India. AIDS Care. 2005;17:141–151. [PubMed]
29. Sheikh K, Rangan S, Kielmann K, Deshpande S, Datye V, Porter J. Private providers and HIV testing in Pune, India: challenges and opportunities. AIDS Care. 2005;17:757–766. [PubMed]
30. Jack A. We need privacy, but not secrecy. Financial Times. August 8, 2005. Available at: http://search.ft.com/ftArticle?querytext=we+need+privacy+not+secrecy89=08aje=true84=08id-050808006847. Accessed August 19, 2007.
31. National HIV/AIDS and STD Control Program of Kenya. Guidelines for HIV Testing in Clinical Settings. Nairobi: Kenya Ministry of Health; 2004.
32. Singapore to inform spouses of HIV patients. Reuters. December 2006. Available at: http://www.medscape.com/viewarticle/518513. Accessed August 19, 2007.
33. Antelman G, Smith Fawzi MC, Kaaya S, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15:1865–1874. [PubMed]
34. Cartoux M, Msellati P, Meda N, et al. Attitude of pregnant women towards HIV testing in Abidjan, Cote d’Ivoire and Bobo-Dioulasso, Burkina Faso. AIDS. 1998;12:2337–2344. [PubMed]
35. D’Angelo LJ, Abdalian SE, Sarr M, Hoffman N, Belzer M, Adolescent Medicine HIV/AIDS Research Network. Disclosure of serostatus by HIV infected youth: the experience of the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 2001;29(3 suppl):72–79. [PubMed]
36. Erwin J, Morgan M, Britten N, Gray K, Peters B. Pathways to HIV testing and care by black African and white patients in London. Sex Transm Infect. 2002; 78(1):37–39. [PMC free article] [PubMed]
37. Fylkesnes K, Siziya S. A randomized trial on acceptability of voluntary HIV counselling and testing. Trop Med Int Health. 2004;9:566–572. [PubMed]
38. Gielen AC, McDonnell KA, Burke JG, O’Campo P. Women’s lives after an HIV-positive diagnosis: disclosure and violence. Matern Child Health J. 2000;4(2): 111–120. [PubMed]
39. Heyward WL, Batter VL, Malulu M, et al. Impact of HIV counseling and testing among child-bearing women in Kinshasa, Zaire. AIDS. 1993;7(12):1633–1637. [PubMed]
40. Hightow LB, Miller WC, Leone PA, Wohl D, Smurzynski M, Kaplan AH. Failure to return for HIV posttest counseling in an STD clinic population. AIDS Educ Prev. 2003;15:282–290. [PubMed]
41. Hope R. Women’s Experiences With HIV Serodisclosure in Africa: Implications for VCT and PMTCT. Washington, DC: USAID; 2004.
42. Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999;18(3):281–287. [PubMed]
43. Keogh P, Allen S, Almedal C, Temahagili B. The social impact of HIV infection on women in Kigali, Rwanda: a prospective study. Soc Sci Med. 1994;38(8): 1047–1053. [PubMed]
44. Kiarie J, Nduati R, Koigi K, Musia J, John G. HIV-1 testing in pregnancy: acceptability and correlates of return for test results. AIDS. 2000;14:1468–1470. [PubMed]
45. Killewo C, Massawe A, Lyamuya E, et al. HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2001; 28:458–462. [PubMed]
46. Ladner J, Leroy V, Msellati P, et al. A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women: Kigali, Rwanda, 1992–1993. AIDS. 1996;10:69–75. [PubMed]
47. Lie GT, Biswalo PM. HIV-positive patient’s choice of a significant other to be informed about the HIV-test result: findings from an HIV/AIDS counselling programme in the regional hospitals of Arusha and Kilimanjaro, Tanzania. AIDS Care. 1996;8(3):285–296. [PubMed]
48. Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS. Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Cent Afr J Med. 1998;44:98–102. [PubMed]
49. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M. Women’s barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001;13:595–603. [PubMed]
50. Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003;7:373–382. [PubMed]
51. Mkaya Mwamburi D, Dladla N, Qwana E, Lurie MN. Factors associated with wanting to know HIV results in South Africa. AIDS Patient Care STDS. 2005;19: 518–525. [PubMed]
52. Molitor F, Bell RA, Truax SR, Ruiz JD, Sun RK. Predictors of failure to return for HIV test result and counseling by test site type. AIDS Educ Prev. 1999;11: 1–13. [PubMed]
53. Nebie Y, Meda N, Leroy V, et al. Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr. 2001;28(4): 367–372. [PubMed]
54. Passin WF, Kim AS, Hutchinson AB, et al. A systematic review of HIV partner counseling and referral services: client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis. 2006; 33(2):1–9. [PubMed]
55. Sahlu T, Kassa E, Agonafer T, et al. Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia. AIDS. 1999;13:1263–1272. [PubMed]
56. Stein JA, Nyamathi A. Gender differences in behavioural and psychosocial predictors of HIV testing and return for test results in a high-risk population. AIDS Care. 2000;12:343–356. [PubMed]
57. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. J Acquir Immune Defic Syndr. 2004;35:511–518. [PubMed]
58. Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plan. 2005;20(2): 109–116. [PubMed]
59. Wurcel A, Zaman T, Zhen S, Stone D. Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study of rapid versus standard testing. AIDS Patient Care STDS. 2005; 19(8):499–505. [PubMed]
60. Coovadia HM. Access to voluntary counseling and testing for HIV in developing countries. Ann N Y Acad Sci. 2000;918:57–63. [PubMed]
61. Cartoux M, Meda N, Van de Perre P, Newell ML, de Vicenzi I, Dabis F. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS. 1998;12(18):2489–2493. [PubMed]
62. Wiley DJ, Frerichs RR, Ford WL, Simon PA. Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted disease clinics. Sex Transm Dis. 1998;25:342–345. [PubMed]
63. Mseleku M, Smith TH, Guidozzi F. HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screening. BJOG. 2005;112(3): 370–371. [PubMed]
64. DeGraft-Johnson J, Paz-Soldan V, Kasote A, Tsui A. HIV voluntary counseling and testing service preferences in a rural Malawi population. AIDS Behav. 2005; 9(4):475–484. [PubMed]
65. Bingham T, McFarland W, Shehan DA, et al. Unrecognized HIV infection, risk behaviors, and perceptions of risk among young black men who have sex with men—six US cities, 1994–1998. JAMA. 2002;288:1344–1348. [PubMed]
66. Campbell C, Bernhardt S. Factors that contribute to women declining antenatal HIV testing. Health Care Women Int. 2003;24:544–551. [PubMed]
67. Worthington C, Myers T. Factors underlying anxiety in HIV testing: risk perceptions, stigma, and the patient–provider power dynamic. Qual Health Res. 2003; 13:636–655. [PubMed]
68. Killewo JZ, Kwesigabo G, Comoro C, et al. Acceptability of voluntary HIV testing with counselling in a rural village in Kagera, Tanzania. AIDS Care. 1998; 10(4):431–439. [PubMed]
69. Jiraphongsa C, Danmoensawat W, Greenland S, et al. Acceptance of HIV testing and counselling among unmarried young adults in northern Thailand. AIDS Educ Prev. 2002;14:89–101. [PubMed]
70. Boyd FM, Simpson WM, Hart GJ, Johnstone FD, Goldberg DJ. What do pregnant women think about the HIV test? A qualitative study. AIDS Care. 1999;11: 21–29. [PubMed]
71. Jha S, Gee H, Coomarasamy A. Women’s attitudes to HIV screening in pregnancy in an area of low prevalence. BJOG. 2003;110(2):145–148. [PubMed]
72. Meadows J, Catalan J, Gazzard B. “I plan to have the HIV test”—predictors of testing intention in women attending a London antenatal clinic. AIDS Care. 1993; 5:141–148. [PubMed]
73. Bastos F, Hacker M. Brazilian psychosocial and operational research vis-à-vis the UNGASS targets [in Portuguese]. Rev Saude Publica. 2006;40(suppl):42–51. [PubMed]
74. Ventura-Filipe E, Bugamelli L, Leme B, et al. Risk perception and counselling among HIV-positive women in Sao Paulo, Brazil. Int J STD AIDS. 2000;11: 112–114. [PubMed]
75. Biehl J, Coutinho D, Outeiro AL. Technology and effect: HIV/AIDS testing in Brazil. Cult Med Psychiatry. 2001;25(1):87–129. [PubMed]
76. Campbell C. Letting Them Die: Why HIV/AIDS Prevention Programs Fail. Bloomington: Indiana University Press; 2003.
77. Castle S. Doubting the existence of AIDS: a barrier to voluntary HIV testing and counselling in urban Mali. Health Policy Plan. 2003;18(2):146–155. [PubMed]
78. Goodman E, Chesney MA, Tipton AC. Relationship of optimism, knowledge, attitudes, and beliefs to use of HIV antibody testing by at-risk female adolescents. Psychosom Med. 1995;57:541–546. [PubMed]
79. Tan TY, Teo KP, Tan KH. Antenatal HIV screening—knowledge, attitudes and practices of obstetricians in KKH. Singapore Med J. 1999;40(12):733–737. [PubMed]
80. Hutchinson AB, Corbie-Smith G, Thomas SB, Mohanan S, del Rio C. Understanding the patient’s perspective on rapid and routine HIV testing in an inner-city urgent care center. AIDS Educ Prev. 2004;16: 101–114. [PubMed]
81. Sliep Y, Poggenpoel M, Gmeiner A. The experience of HIV reactive patients in rural Malawi—part I. Curationis. 2001;3:56–65. [PubMed]
82. Phillips KA, Coates TJ, Catania JA. Predictors of follow-through on plans to be tested for HIV. Am J Prev Med. 1997;13(3):193–198. [PubMed]
83. WHO. The Right To Know: New Approaches to HIV Testing and Counselling. Geneva, WHO; 2003.
84. Temmerman M, Ndinya-Achola J, Ambani J, Piot P. The right not to know HIV-test results. Lancet. 1995; 345:969–970. [PubMed]
85. Flowers P, Knussen C, Duncan B. Re-appraising HIV testing among Scottish gay men: the impact of new HIV treatments. J Health Psychol. 2001;6: 665–678. [PubMed]
86. Lupton D, McCarthy S, Chapman S. “Doing the right thing”: the symbolic meanings and experiences of having an HIV antibody test. Soc Sci Med. 1995;41: 173–180. [PubMed]
87. Moore A, Candlin CN, Plum GA. Making sense of HIV-related viral load: one expert or two? Culture. 2001;3:429–450.
88. Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4:167–189.
89. Sobo EJ. Attitudes toward HIV testing among impoverished inner-city African-American women. Med Anthropol. 1994;16:17–38. [PubMed]
90. Sobo EJ. Human immunodeficiency virus seropositivity self-disclosure to sexual partners: a qualitative study. Holist Nurs Pract. 1995;10:18–28. [PubMed]
91. Chandra P, Deepthivarma S, Manjula V. Disclosure of HIV infection in south India: patterns, reasons, and reactions. AIDS Care. 2003;15:207–215. [PubMed]
92. Klitzman R, Bayer R. Mortal Secrets: Truth and Lies in the Age of AIDS. Baltimore, Md: Johns Hopkins University Press; 2003.
93. Cusick L. The process of disclosing positive HIV status: findings from qualitative research. Cult Health Sex. 1999;1:3–18.
94. Coulibaly D, Msellati P, Dedy S, Welffens-Ekra C, Dabis F. Attitudes and behavior of pregnant women towards HIV screening in Abidjan (Ivory Coast) in 1995 and 1996. Sante. 1998;8(3):234–238. [PubMed]
95. Ginwalla SK, Grant AD, Day JH, et al. Use of UNAIDS tools to evaluate HIV voluntary counselling and testing services for mineworkers in South Africa. AIDS Care. 2002;14:707–726. [PubMed]
96. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4): 299–307. [PMC free article] [PubMed]
97. Aka-Dago-Akribi H, Du Lou AD, Msellati P, Doussou R, Welffens-Ekra C. Issues surrounding reproductive choice for women living with HIV in Abidjan, Cote d’Ivoire. Reprod Health Matters. 1999;7: 20–29.
98. Bond L, Lauby J, Batson H. HIV testing and the role of individual- and structural-level barriers and facilitators. AIDS Care. 2005;17:125–140. [PubMed]
99. Das S, Huengsberg M, Radcliffe K. Impact of information leaflets on HIV test uptake amongst GUM clinic attendees: an update. Int J STD AIDS. 2004; 15(6):422–423. [PubMed]
100. de Paoli MM, Manongi R, Klepp K-I. Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in northern Tanzania. AIDS Care. 2004;16(4):411–425. [PubMed]
101. Gaillard P, Melis R, Mwanyumba F, et al. Vulnerability of women in an African setting: lessons for mother-to-child HIV transmission prevention programmes. AIDS. 2002;16:937–939. [PubMed]
102. Laver SM. Voluntary testing and counselling for HIV. “Are adults in rural communities ready to test?” A descriptive survey. Cent Afr J Med. 2001;47(4):92–97. [PubMed]
103. Kalichman SC, Cain D, Weinhardt LS, et al. Experimental components analysis of brief-theory based HIV/AIDS risk-reduction counseling for sexually transmitted infection patients. Health Psychol. 2005;24: 198–208. [PubMed]
104. Murphy DA, Mitchell R, Vermund SH, Futterman D, Adolescent Medicine HIV/AIDS Research Network. Factors associated with HIV testing among HIV-positive and HIV-negative high-risk adolescents: the REACH Study. Reaching for Excellence in Adolescent Care and Health. Pediatrics. 2002;110(3):e36. [PubMed]
105. Paxton S, Gonzales G, Uppakaew K, et al. AIDS-related discrimination in Asia. AIDS Care. 2005;17: 413–424. [PubMed]
106. Hirose H, Nakaune N, Ishizuka T, Tsuchida S, Takanashi Y. A study on the role of AIDS mass communication: how do the mass media affect HIV testing behavior? Jpn Psychol Res. 1998;40:246–255.
107. Rogstad KE, Bramham L, Lowbury R, Kinghorn GR. Use of a leaflet to replace verbal pretest discussion for HIV: effects and acceptability. Sex Transm Infect. 2003; 79(3):243–245. [PMC free article] [PubMed]
108. Simpson WM, Johnstone FD, Hart GJ, Boyd FM, Goldberg DJ. To test or not to test? What makes pregnant women decide to take an HIV test? Psychol Health Med. 1998;3:327–335.
109. Reiss TH, Kim C, Downing M. Motives for HIV testing among drug users: an analysis of gender differences. AIDS Educ Prev. 2001;13:509–534. [PubMed]
110. Bajos N, Ducot B, Spencer A, Spira, ACSF Group. Sexual risk-taking, socio-sexual biographies and sexual interaction: elements of the French national survey on sexual behavior. Soc Sci Med. 1997;44(1):25–40.
111. Nyblade LC, Menken J, Wawer MJ, et al. Population-based HIV testing and counseling in rural Uganda: participation and risk characteristics. J Acquir Immune Defic Syndr. 2001;28(5):463–470. [PubMed]
112. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health. 2005;10:1242. [PubMed]
113. van Dyk AC, van Dyk PJ. “What is the point of knowing?” Psychosocial barriers to HIV/AIDS voluntary counselling and testing programmes in South Africa. S Afr J Psychol. 2003;33:118–125.
114. Gaillard P, Meilis R, Mwanyumba F, et al. Consequences of announcing HIV seropositivity to women in an African setting: lessons for the implementation of HIV testing and interventions to reduce mother-to-child HIV transmission. Paper presented at: XIII International AIDS Conference; July 9–14, 2000; Durban, South Africa.
115. Gielen AC, McDonnell KA, Wu A, O’Campo P, Faden RR. Quality of life among women living with HIV: the importance of violence, social support, and self care behaviors. Soc Sci Med. 2001;52:315–322. [PubMed]
116. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M, Weiss E. HIV and Partner Violence: Implications for HIV Voluntary Counseling and Testing Programs in Dar es Salaam, Tanzania. Washington, DC: Population Council Horizons Project; 2001.
117. Shankar AV, Pisal H, Patil O, et al. Women’s acceptability and husband’s support of rapid HIV testing of pregnant women in India. AIDS Care. 2003;15:871–874. [PubMed]
118. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Prentice-Hall; 1963.
119. Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11:353–363. [PubMed]
120. Van Brakel WH. Measuring health-related stigma—a literature review. Psychol Health Med. 2006;11: 307–334. [PubMed]
121. Herek GM, Capitanio JP, Widaman KF. Stigma, social risk, and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychol. 2003;22:533–540. [PubMed]
122. Herek GM, Capitanio JP. AIDS stigma and sexual prejudice. Am Behav Sci. 1999;42:1130–1147.
123. Day JH, Miyamura K, Grant AD, et al. Attitudes to HIV voluntary counselling and testing among mineworkers in South Africa: will availability of antiretroviral therapy encourage testing? AIDS Care. 2003;15:665–672. [PubMed]
124. Ford K, Wirawan DN, Sumantera GM, Sawitri AA, Stahre M. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev. 2004;16(6):487–498. [PubMed]
125. Fortenberry JD, McFarlane M, Bleakley A, et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health. 2002;92:378–381. [PMC free article] [PubMed]
126. Gilmore N, Somerville MA. Stigmatization, scape-goating and discrimination in sexually transmitted diseases: overcoming “them” and “us.” Soc Sci Med. 1994; 39:1339–1358. [PubMed]
127. Golin C, Isasi F, Breny Bontempi J, Eng E. Secret pills: HIV-positive patients’ experiences taking antiretro-viral therapy in North Carolina. AIDS Educ Prev. 2002; 14:318–329. [PubMed]
128. Addressing HIV Related Stigma and Resulting Discrimination in Africa: A Three-Country Study in Ethiopia, Tanzania and Zambia. Washington, DC: International Center for Research on Women; 2002.
129. Kalichman SC, Simbayi L. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79:442–447. [PMC free article] [PubMed]
130. Mill JE. Shrouded in secrecy: breaking the news of HIV infection to Ghanaian women. J Transcult Nurs. 2003;14:6–16. [PubMed]
131. Parra EO, Doran TI, Ivy LM, Aranda JM, Hernandez C. Concerns of pregnant women about being tested for HIV: a study in a predominately Mexican-American population. AIDS Patient Care STDS. 2001;15(2):83–93. [PubMed]
132. Pool R, Nyanzi S, Whitworth JAG. Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care. 2001;13:605–615. [PubMed]
133. Tangmunkongvorakul A, Celentano DD, Burke JG, De Boer MA, Wongpan P, Suriyanon V. Factors influencing marital stability among HIV discordant couples in northern Thailand. AIDS Care. 1999;11:511–524. [PubMed]
134. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–288. [PubMed]
135. Yoshioka MR, Schustack A. Disclosure of HIV status: cultural issues of Asian patients. AIDS Patient Care STDS. 2001;15:77–82. [PubMed]
136. Bishop GD, Oh HM, Swee HY. Attitudes and beliefs of Singapore health care professionals concerning HIV/AIDS. Singapore Med J. 2000;41(2):55–63. [PubMed]
137. Foreman M, Lyra P, Breinbauer C. Understanding and Responding to HIV/AIDS-Related Stigma and Stigma and Discrimination in the Health Sector. Washington, DC: Pan American Health Organization; 2003.
138. Chi BH, Chansa K, Gardner MO, et al. Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: a survey of maternity-based health care providers in Zambia. Int J STD AIDS. 2004;15: 685–690. [PubMed]
139. Scherr L, Hackman N, Mfenyana K, Chandia J, Yogeswaran P. Antenatal HIV testing from the perspective of pregnant women and health clinic staff in South Africa: implications for pre- and post-test counselling. Couns Psychol Q. 2003;16:337–347.
140. Nyblade LC. Measuring HIV stigma: existing knowledge and gaps. Psychol Health Med. 2006;11:335–345. [PubMed]
141. Deacon H, Stephney I, Prosalendis S. Understanding HIVAIDS Stigma: A Theoretical and Methodological Analysis. Cape Town, South Africa: HSRC Press; 2005.
142. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57: 13–24. [PubMed]
143. Reidpath DD, Chan KY. A method for the quantitative analysis of the layering of HIV-related stigma. AIDS Care. 2005;17:425–432. [PubMed]
144. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned. AIDS Educ Prev. 2003;15:49–69. [PubMed]
145. Ogden J, Nyblade L. Common at its core: HIV-related stigma across contexts. Washington, DC: International Center for Research on Women; 2005.
146. Policy Project. Siyam’Kela HIV/AIDS stigma indicators: a tool for measuring the progress of HIV/AIDS stigma mitigation. 2004. Available at: http://www.policyproject.com/siyamkela.cfm. Accessed July 31, 2007.
147. Nyblade L, MacQuarrie K, Phillip F, et al. Working Report Measuring HIV Stigma: Results of a Field Test in Tanzania. Washington, DC: Synergy; 2005.
148. Gibney L, Wade S, Madzime S, Mbizvo M. HIV testing practices of Zimbabwean physicians and their perspectives on the future use of rapid on-site tests. AIDS Care. 1999;11:663–673. [PubMed]
149. Ruiz JD, Molitor F, Prussing E, Peck L, Grasso P. Prenatal HIV counseling and testing in California: women’s experiences and providers’ practices. AIDS Educ Prev. 2002;14:190–195. [PubMed]
150. Brown KH. Descriptive and normative ethics: class, context and confidentiality for mothers with HIV. Soc Sci Med. 1993;36:195–202. [PubMed]
151. Brouwer CN, Lok CL, Wolffers I, Sebagalls S. Psychosocial and economic aspects of HIV/AIDS and counselling of caretakers of HIV-infected children in Uganda. AIDS Care. 2000;12(5):535–540. [PubMed]
152. de Paoli MM, Manongi R, Klepp KI. Counsellors’ perspectives on antenatal HIV testing and infant feeding dilemmas facing women with HIV in northern Tanzania. Reprod Health Matters. 2002;10(20):144–156. [PubMed]
153. Sherr L, Bergenstrom A, Bell E, McCann E, Hudson CN. Ante-natal HIV testing: an observational study of HIV test discussion in maternity care. Couns Psychol Q. 2001;14:129–138.
154. Sliep Y, Poggenpoel M, Gmeiner A. A care counselling model for HIV reactive patients in rural Malawi—part II. Curationis. 2001;3:66–74. [PubMed]
155. Zimba C, Kamanga E, Chilongozi D, et al. Impact of routine HIV counseling and testing with an opt-out strategy compared to voluntary counseling and testing in the implementation of PMTCT services, Lilongwe, Malawi. Paper presented at: XVI International AIDS Conference; August 13–18, 2006; Toronto, Canada.
156. Halpern SD. Towards evidence based bioethics. BMJ. 2005;331:901–903. [PMC free article] [PubMed]
157. Obermeyer CM. Ethical guidelines for HIV research: a contextual implementation process. J Int Bioethique. 2004;15:95–104. [PubMed]
158. Muller JH. Anthropology, bioethics, and medicine: a provocative trilogy. Med Anthropol Q. 1994;8: 448–467.
159. Marshall PA. Informed consent in international health research. In: CIOMS Nonserial, ed. Biomedical Research Ethics: Updating International Guidelines. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS); 2000.
160. Coreil J, Losikoff P, Pincu R, et al. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti. AIDS Educ Prev. 1998;10:46–62. [PubMed]
161. Fitzgerald DW, Marotte C, Verdier RI, Johnson WD, Pape JW. Comprehension during informed consent in a less-developed country. Lancet. 2002;360:1301–1302. [PubMed]
162. Luginaah IN, Yiridoe EK, Taabazuing MM. From mandatory to voluntary testing: balancing human rights, religious and cultural values, and HIV/AIDS prevention in Ghana. Soc Sci Med. 2005;61: 1689–1700. [PubMed]
163. Paasche-Orlow M, Taylor H, Brancati F. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003;348: 721–726. [PubMed]
164. McCann K, Wadsworth E. The experience of having a positive HIV antibody test. AIDS Care. 1991;3: 43–53. [PubMed]
165. McCann K. The impact of receiving a positive HIV antibody test: factors associated with the response. Couns Psychol Q. 1992;5:37–45.
166. Schrooten W, Dreezen C, Fleerackers Y, et al. Receiving a positive HIV test result: the experience of patients in Europe. HIV Med. 2001;2(4):250–254. [PubMed]
167. Yoder PS, Konate MK. Obtaining Informed Consent for HIV Testing: The DHS Experience in Mali. Calverton, Md: ORC Macro; 2002.
168. Mitchell K, Nakamanya S, Kamali A, Whitworth JA. Balancing rigour and acceptability: the use of HIV incidence to evaluate a community-based randomised trial in rural Uganda. Soc Sci Med. 2002;54:1081–1091. [PubMed]
169. Weiser SD, Heisler M, Leiter K, et al. Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3(7):e261. [PMC free article] [PubMed]
170. Abdool Karim Q, Abdool Karim SS, Coovadia HM, Susser M. Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary? Am J Public Health. 1998;88(4):637–640. [PMC free article] [PubMed]
171. Williams AB. Report from the field: participation of HIV-positive women in clinical research. AIDS Public Policy J. 1997;12:46–52. [PubMed]
172. Leach A, Hilton S, Greenwood BM, et al. An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med. 1999;48:139–148. [PubMed]
173. Seidel G. Confidentiality and HIV status in Kwazulu-Natal, South Africa: implications, resistances and challenges. Health Policy Plan. 1996;11(4):418–427. [PubMed]
174. Grusky O, Roberts KJ, Swanson AN, et al. Anonymous versus confidential HIV testing: client and provider decision making under uncertainty. AIDS Patient Care STDS. 2005;19:157–166. [PubMed]
175. Duffy TA, Wolfe CD, Varden C, Kennedy J, Chrystie IL. Women’s knowledge and attitudes, and the acceptability of voluntary antenatal HIV testing. BJOG. 1998;105(8):849–854. [PubMed]
176. Nuwaha F, Katabesi D, Muganwa M, Whalen C. Factors in influencing acceptability of voluntary counseling and testing in Busheny district of Uganda. East Afr Med J. 2002;79:626–632. [PMC free article] [PubMed]
177. Barnes DB, Alforque A, Carter K. “Like I just got a death sentence”: conditions affecting women’s reactions to being told their HIV antibody test results and the impact on access to care. Res Sociol Health Care. 2000;18:3–33.
178. Pronyk PM, Kim JC, Makhubele MB, Hargreaves JR, Mohlala R, Hausler HP. Introduction of voluntary counselling and rapid testing for HIV in rural South Africa: from theory to practice. AIDS Care. 2002;14: 859–865. [PubMed]
179. Serafim D, Ferraz D, Chequer P. Counseling in the use of anti-HIV rapid testing: the experience of the Brazilian AIDS program. Paper presented at: XVI International AIDS Conference; August 13–18, 2006; Toronto, Canada.
180. Anderson JE, Koenig LJ, Lampe MA, Wright R, Leiss J, Saul J. Achieving universal HIV screening in prenatal care in the United States: provider persistence pays off. AIDS Patient Care STDS. 2005;19:247–252. [PubMed]
181. Marelich WD, Johnston RK, Murphy DA, Callari T. HIV/AIDS patient involvement in antiretroviral treatment decisions. AIDS Care. 2002;14(1):17–26. [PubMed]
182. Tambashe B, Speizer I, Amouzou A, Djangone A. Evaluation of the PSAMAO “Roulez Protege” mass media campaign in Burkina Faso. Prevention du SIDA sur les Axes Migratoires de l’Afrique de l’Ouest. AIDS Educ Prev. 2003;15:33–48. [PubMed]
183. Apanovitch AM, McCarthy D, Salovey P. Using message framing to motivate HIV testing among low-income, ethnic minority women. Health Psychol. 2003; 22(1):60–67. [PubMed]
184. Kalichman SC, Coley B. Context framing to enhance HIV-antibody-testing messages targeted to African American women. Health Psychol. 1990;3:247–254. [PubMed]
185. Corbett E, Dauya E, Matambo R, et al. Uptake of workplace HIV counseling and testing: a cluster-randomised trial in Zimbabwe. PloS Med. 2006;3(7): e238. [PMC free article] [PubMed]
186. Mermin J, Bunnell R, Lule J, et al. Developing and evidence-based preventive care package for persons with HIV in Africa. Trop Med Int Health. 2005;10(10): 961–970. [PubMed]
187. Rotheram-Borus MJ, Leibowitz AA, Etzel MA. Routine, rapid HIV testing. AIDS Educ Prev. 2006; 18(3):273–280. [PubMed]
188. Day S, Lakhani D, Hankins M, Rodgers CA. Improving uptake of HIV testing in patients with a confirmed STI. Int J STD AIDS. 2004;15(9):626–628. [PubMed]
189. Mahto M, Higgins SP. Increased uptake of HIV screening following introduction of “opt out” testing and results by telephone. Sex Transm Infect. 2004;80:156. [PMC free article] [PubMed]
190. Yoder PS, Katahoire AR, Kyaddondo D, Akol Z, Bunnel R. Home-Based Testing and Counseling in a Survey Context in Uganda. Calverton, Md: ORC Macro; 2006.
191. Perez F, Zvandaziva C, Engelsmann B, Dabis F. Acceptability of routine HIV testing (“opt-out”) in two rural districts of Zimbabwe. J Acquir Immune Defic Syndr. 2006;4:514–520. [PubMed]
192. Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ. Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ. 1998;316(7127): 262–267. [PMC free article] [PubMed]
193. Etiebet M-A, Fransman D, Forsyth B, Coetzee N, Hussey G. Integrating prevention of mother-to-child HIV transmission into antenatal care: learning from the experiences of women in South Africa. AIDS Care. 2004;16:37–46. [PubMed]
194. Greenwald JL. Routine rapid HIV testing in hospitals: another opportunity for hospitalists to improve care. J Hosp Med. 2006;1(2):106–112. [PubMed]
195. Corneli A, Jarrett N, Tabala M, et al. Patient and provider perspectives on improving access to HIV testing and counselling for TB patients in Kinshasa, Democratic Republic of Congo (DRC). Paper presented at: 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment; July 24–27, 2005; Rio de Janeiro, Brazil.
196. Thior I, Gabaitiri L, Grimes J, et al. Voluntary counseling and testing among post-partum women in Botswana. Patient Educ Couns. 2007;65(3):296–302. [PMC free article] [PubMed]
197. Kankasa C, Katepa-Bwalya M, Butlerys M, et al. Routine and universal counseling and testing among hospitalized children at University Teaching Hospital, Lusaka, Zambia. Paper presented at: President’s Emergency Plan for AIDS Relief Implementers Meeting; June 12–15, 2006; Durban, South Africa.
198. Nawavvu C, Wanyeze R, Namale A, Freers J. Routine HIV testing for children: challenges and lessons learned. Paper presented at: President’s Emergency Plan for AIDS Relief Implementers Meeting; June 12–15, 2006; Durban, South Africa.
199. Homsy J, et al. Routine intrapartum HIV counseling and testing for prevention of mother-to-child transmission of HIV in a rural Ugandan hospital. J Acquir Immune Defic Syndr. 2006;42:149–154. [PubMed]
200. Semafumu E, Ngabirano T. Building on the success of STD programmes to increase access to prevention and care for HIV/AIDS: the case for routine testing and counseling in STD patients. Paper presented at: President’s Emergency Plan for AIDS Relief Implementers Meeting; June 12–15, 2006; Durban, South Africa.
201. Andia I. evolving clinical picture secondary to routine HIV testing and early linkage to care at the HIV clinic at Mbarara Regional Referral Hospital. Paper presented at: President’s Emergency Plan for AIDS Relief Implementers Meeting; June 12–15, 2006; Durban, South Africa.
202. Steen TW, Seipone K, Gomez Fde L, et al. Two and a half years of routine HIV testing in Botswana. J Acquir Immune Defic Syndr. 2007;44(4):484–488. [PubMed]
203. Miller A. Pilot implementation of revised national policy for routine offer of HIV testing in antenatal services: quantitative and qualitative impact in urban and rural Zimbabwe. Paper presented at: President’s Emergency Plan for AIDS Relief Implementers Meeting; June 12–15, 2006; Durban, South Africa.

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...